Peer-Reviewed Publications
Years of Dedicated Research
A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity
Transient overexpression of hPKM2 in porcine cardiomyocytes prevents heart failure after myocardial infarction
Pyruvate Kinase M2 Role in Cardiovascular Repair
Harnessing mRNA technology for ischemic heart disease: a review of regenerative and protective therapies
Novel Artificial 5′UTR Increase Modified mRNA Translation When Injected into Mouse Heart
The Potential of RNA Therapeutics in Treating Cardiovascular Disease
Modified mRNA-Mediated CCN5 Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling
Lin28a cardiomyocyte-specific modified mRNA translation system induces cardiomyocyte cell division and cardiac repair
Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts with Myocardial Infarction in Mice and Pigs
Extracellular Vesicle-Encapsulated AAVs for Therapeutic Gene Delivery to the Heart
Activation of a transient progenitor state in the epicardium is required for zebrafish heart regeneration
Direct reprogramming induces vascular regeneration post muscle ischemic injury
Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
SMRTs: Specific modified mRNA Translation system
In Vitro Synthesis of Modified RNA for Cardiac Gene Therapy
Modified mRNA as a Therapeutic Tool for the Heart
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Optimization of 5′ Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury
Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration
Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction
Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy
mRNA-Based Protein Replacement Therapy for the Heart
Cardiac Sca-1+ cells are not intrinsic stem cells for myocardial development, renewal and repair
Ablation of a Single N-Glycosylation Site in Human FSTL 1 Induces Cardiomyocyte Proliferation and Cardiac Regeneration
Synthetic MicroRNAs Stimulate Cardiac Repair
Optimizing Cardiac Delivery of Modified mRNA
Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease
Synthesis of Modified mRNA for Myocardial Delivery
An IGF1R-dependent pathway drives epicardial adipose tissue formation after myocardial injury
Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells
Synthetic Chemically Modified mRNA (modRNA): Toward a New Technology Platform for Cardiovascular Biology and Medicine
Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA
